---
title: Forensic Toxicology
order: 3
category: Forensic Pathology
status: complete
last_updated: '2025-01-09'
---

# Forensic Toxicology

## Overview
Forensic toxicology is the study of drugs, chemicals, and poisons in biological specimens for legal purposes. In postmortem forensic pathology, toxicology plays a critical role in determining cause of death, identifying contributing factors, and providing evidence for legal proceedings. Understanding specimen collection, analytical methods, and interpretation of results is essential for accurate death investigation.

## Principles of Forensic Toxicology

### Scope and Applications
1. **Postmortem Toxicology**
   - Cause of death determination
   - Contributory factor identification
   - Blood alcohol/drug concentration
   - Poisoning investigation

2. **Human Performance Toxicology**
   - Driving under the influence (DUI)
   - Workplace drug testing
   - Impairment assessment

3. **Drug-Facilitated Crimes**
   - Sexual assault investigation
   - Drug-facilitated robbery
   - Involuntary intoxication

### Fundamental Concepts

#### Pharmacokinetics (ADME)
1. **Absorption**
   - Route-dependent (oral, IV, inhalation, dermal)
   - First-pass metabolism (oral route)
   - Bioavailability variations

2. **Distribution**
   - Volume of distribution (Vd)
   - Protein binding
   - Tissue accumulation
   - Blood-brain barrier penetration

3. **Metabolism**
   - Phase I reactions (oxidation, reduction, hydrolysis)
   - Phase II reactions (conjugation)
   - Cytochrome P450 enzymes
   - Active metabolites vs. inactive

4. **Excretion**
   - Renal elimination (urine)
   - Hepatic elimination (bile/feces)
   - Pulmonary (volatile substances)
   - Minor routes (sweat, saliva)

#### Pharmacodynamics
- **Dose-Response Relationship**: Effect intensity vs. concentration
- **Therapeutic Range**: Efficacious without toxicity
- **Toxic Range**: Adverse effects occur
- **Lethal Range**: Life-threatening concentrations
- **Tolerance**: Decreased response with chronic use
- **Sensitization**: Increased response with repeated exposure

#### Toxicokinetics
- **Postmortem Redistribution**: Drug movement after death
- **Decomposition Effects**: Chemical changes in tissues
- **Artifact Formation**: Non-drug substances appearing in analysis
- **Specimen Stability**: Degradation over time

## Specimen Collection and Preservation

### Antemortem Specimens

#### Blood
- **Collection Time**: Document relative to incident
- **Site**: Peripheral venous preferred
- **Volume**: Minimum 10 mL (gray-top tube for alcohol)
- **Additives**: Sodium fluoride (preservative), potassium oxalate (anticoagulant)
- **Storage**: Refrigeration (4°C) or freezing (-20°C)

#### Urine
- **Complete Void**: Entire bladder contents
- **Volume**: Minimum 30-50 mL
- **Window of Detection**: Days to weeks (longer than blood)
- **Qualitative Screening**: Presence/absence determination

### Postmortem Specimens

#### Blood
**Peripheral Blood (Preferred)**:
- **Site**: Femoral vein (avoid contamination)
- **Rationale**: Less postmortem redistribution
- **Volume**: 25-50 mL minimum
- **Container**: Gray-top tube or clean glass container
- **Preservatives**: Sodium fluoride (1%) prevents bacterial fermentation

**Central Blood (Supplementary)**:
- **Site**: Cardiac chambers, subclavian vein
- **Caution**: Higher concentrations due to redistribution
- **Use**: Comparison with peripheral; some drugs only
- **Not for**: Alcohol (falsely elevated)

#### Vitreous Humor
- **Collection**: Both eyes, separate containers
- **Volume**: 1-3 mL per eye
- **Advantages**: Protected from contamination, stable
- **Applications**: Alcohol, glucose, electrolytes, some drugs
- **Interpretation**: Equilibrates with blood but slower

#### Urine
- **Collection**: Complete bladder contents
- **Volume**: All available (may be limited postmortem)
- **Advantages**: High concentrations, long detection window
- **Limitations**: Qualitative only; timing uncertain postmortem

#### Liver
- **Sample Site**: Peripheral section (avoid central necrosis)
- **Weight**: 50-100 grams
- **Advantages**: High concentrations of lipophilic drugs
- **Applications**: Chronic exposure, drug accumulation
- **Interpretation**: Must correlate with blood levels

#### Gastric Contents
- **Collection**: Complete stomach contents
- **Volume**: Document total volume
- **Significance**: Recent oral ingestion evidence
- **Limitations**: Variable absorption; not quantitative
- **Findings**: Pills, capsules, plant material, odors

#### Bile
- **Volume**: 5-10 mL
- **Application**: Blood alternative in decomposition
- **Advantages**: Concentrated metabolites
- **Limitations**: Limited reference ranges

#### Brain
- **Indication**: Volatile substances (inhalants, solvents)
- **Sample**: 50 grams
- **Storage**: Frozen, airtight container
- **Application**: Lipid-soluble compounds concentrate

#### Hair and Nails
- **Hair**: Chronic exposure (months to years)
- **Segmental Analysis**: Timeline of use
- **Limitations**: Environmental contamination, treatment effects
- **Nails**: Alternative to hair; slower growth

#### Other Tissues
- **Kidney**: Alternative to liver
- **Lung**: Inhaled substances
- **Bone/Marrow**: Chronic metal exposure
- **Muscle**: Postmortem redistribution concerns

### Special Collection Considerations

#### Decomposed Bodies
- **Specimens Available**: Vitreous, liver, muscle, bone
- **Avoid**: Blood (unreliable)
- **Bone Marrow**: Alternative for metals, some drugs
- **Maggots**: Can contain drugs from body

#### Embalmed Bodies
- **Caution**: Formaldehyde interference
- **Alternatives**: Liver, vitreous (if not replaced)
- **Interpretation**: Document embalming in report

#### Exhumed Bodies
- **Tissue Preservation**: Variable based on conditions
- **Bone**: Metals, some stable drugs
- **Hair/Nails**: Often well-preserved
- **Soil Samples**: Control for environmental contamination

### Chain of Custody
- **Documentation**: Every transfer recorded
- **Sealing**: Tamper-evident containers
- **Storage**: Secure, temperature-controlled
- **Tracking**: Who, what, when, where
- **Legal Admissibility**: Unbroken chain required

## Analytical Methods

### Screening Tests (Presumptive)

#### Immunoassays
**Principle**: Antibody-antigen interaction

**Types**:
- ELISA (Enzyme-Linked Immunosorbent Assay)
- EMIT (Enzyme Multiplied Immunoassay Technique)
- CEDIA (Cloned Enzyme Donor Immunoassay)
- KIMS (Kinetic Interaction of Microparticles in Solution)

**Advantages**:
- Rapid results
- High throughput
- Relatively inexpensive
- Sensitive

**Limitations**:
- Class-specific (not compound-specific)
- Cross-reactivity (false positives)
- Requires confirmation
- Set cutoff concentrations

#### Color Tests
- **Marquis Reagent**: Opiates (purple), amphetamines (orange)
- **Duquenois-Levine**: Cannabis (purple)
- **Scott Test**: Cocaine (blue)
- **Application**: Field testing, rapid screening
- **Limitation**: Presumptive only; many false positives

### Confirmatory Tests (Definitive)

#### Gas Chromatography-Mass Spectrometry (GC-MS)
**Principle**: Separation by GC, identification by MS

**Applications**:
- Volatile compounds (alcohols, solvents)
- Drugs of abuse
- Therapeutic medications
- Semi-volatile toxins

**Advantages**:
- Gold standard for confirmation
- Specific identification
- Quantitative
- Library matching

**Limitations**:
- Requires volatility or derivatization
- Sample preparation intensive
- Not for large molecules

#### Liquid Chromatography-Mass Spectrometry (LC-MS/MS)
**Principle**: Liquid separation, tandem mass spec detection

**Applications**:
- Non-volatile drugs
- Polar compounds
- Large molecules
- Emerging drugs

**Advantages**:
- Minimal sample prep
- High sensitivity
- Broad applicability
- Specific and quantitative

**Limitations**:
- Expensive equipment
- Matrix effects
- Requires expertise

#### High-Performance Liquid Chromatography (HPLC)
**Applications**: Quantitation of known compounds

**Detectors**:
- UV/Visible
- Fluorescence
- Diode array

**Use**: Therapeutic drug monitoring, specific toxins

#### Inductively Coupled Plasma-Mass Spectrometry (ICP-MS)
**Application**: Heavy metals and elements

**Advantages**:
- Multi-element analysis
- Very sensitive
- Wide linear range

### Quality Assurance

#### Validation Parameters
- **Accuracy**: Closeness to true value
- **Precision**: Reproducibility
- **Linearity**: Response vs. concentration
- **Limit of Detection (LOD)**: Lowest detectable amount
- **Limit of Quantitation (LOQ)**: Lowest accurate measurement
- **Selectivity**: Distinguishes from interferences

#### Quality Control
- **Calibrators**: Known concentrations for standard curve
- **Controls**: Known samples run with unknowns
- **Blanks**: Matrix without analyte
- **Proficiency Testing**: External validation

#### Certification and Accreditation
- **Laboratory Accreditation**: ISO/IEC 17025
- **Personnel Certification**: ABC-FT (American Board of Clinical Chemistry)
- **Standards**: SWGTOX, SOFT/AAFS guidelines

## Common Substances in Forensic Toxicology

### Alcohol

#### Ethanol
**Sources**: Alcoholic beverages, mouthwash, medications

**Metabolism**:
- Zero-order kinetics (constant rate ~15-20 mg/dL/hour)
- Alcohol dehydrogenase → acetaldehyde
- Aldehyde dehydrogenase → acetic acid

**Specimens**:
- **Blood**: Gold standard (femoral vein preferred)
- **Vitreous**: Correlates with blood; delayed equilibration
- **Urine**: Higher than blood (concentration factor)

**Interpretation**:
- **0.00-0.05%**: Minimal effects
- **0.05-0.08%**: Impairment (legal limit driving)
- **0.08-0.15%**: Significant impairment
- **0.15-0.30%**: Severe intoxication
- **0.30-0.40%**: Stupor, possible death
- **>0.40%**: Frequently fatal

**Postmortem Considerations**:
- **Microbial Production**: Fluoride preservative essential
- **Putrefaction**: Can produce ethanol artifact
- **Vitreous Ratio**: Blood/vitreous >1.2 suggests antemortem consumption

#### Volatiles and Solvents
- **Methanol**: Toxic metabolite (formic acid); blindness, death
- **Isopropanol**: Metabolite acetone; CNS depression
- **Ethylene Glycol**: Metabolites (oxalic acid); renal failure
- **Toluene, Acetone**: Inhalant abuse
- **Analysis**: Headspace GC-MS

### Drugs of Abuse

#### Opioids
**Natural Opiates**:
- Morphine (heroin metabolite)
- Codeine
- 6-MAM (heroin-specific metabolite)

**Semi-Synthetic**:
- Hydrocodone (Vicodin)
- Hydromorphone (Dilaudid)
- Oxycodone (OxyContin, Percocet)
- Oxymorphone (Opana)

**Synthetic**:
- Fentanyl and analogs (extremely potent)
- Methadone
- Tramadol
- Buprenorphine

**Toxicity**:
- Respiratory depression (mechanism of death)
- CNS depression, miosis
- Pulmonary edema common autopsy finding

**Interpretation Challenges**:
- Tolerance in chronic users
- Wide therapeutic-toxic range
- Fentanyl: ng/mL range (vs. μg/mL for morphine)

#### Stimulants
**Cocaine**:
- Metabolism: Benzoylecgonine (major metabolite)
- Cocaethylene: Cocaine + ethanol (more cardiotoxic)
- Effects: Sympathomimetic, cardiac arrhythmias
- Postmortem redistribution significant

**Amphetamines**:
- Methamphetamine, amphetamine
- MDMA (Ecstasy), MDA
- Effects: Sympathomimetic, hyperthermia
- Interpretation: Therapeutic uses exist (ADHD medications)

#### Cannabis
**Active Compound**: Delta-9-tetrahydrocannabinol (THC)

**Metabolites**:
- 11-OH-THC (active)
- THC-COOH (inactive, detected in urine)

**Detection**:
- Blood: Hours (acute use)
- Urine: Days to weeks (chronic users)
- Hair: Months

**Challenges**:
- Correlation with impairment uncertain
- Lipophilic (stored in fat)
- Passive exposure vs. active use

#### Sedative-Hypnotics
**Benzodiazepines**:
- Diazepam, alprazolam, clonazepam, lorazepam
- Therapeutic and abuse potential
- Enhanced CNS depression with alcohol/opioids
- Long detection window (metabolites)

**Barbiturates**:
- Phenobarbital, secobarbital
- Narrow therapeutic index
- Enzyme induction (tolerance)

**Z-Drugs**:
- Zolpidem, eszopiclone, zaleplon
- Sleep aids; impairment potential

#### Hallucinogens
- **LSD**: Extremely low concentrations
- **Psilocybin/Psilocin**: Mushrooms
- **PCP**: Dissociative anesthetic
- **Ketamine**: Anesthetic, club drug

### Therapeutic Medications

#### Cardiovascular Drugs
- **Digoxin**: Narrow therapeutic index; postmortem redistribution
- **Beta-blockers**: Propranolol, metoprolol
- **Calcium Channel Blockers**: Diltiazem, verapamil
- **Toxicity**: Bradycardia, hypotension, cardiac arrest

#### Antidepressants
**Tricyclics (TCAs)**:
- Amitriptyline, nortriptyline, doxepin
- Cardiotoxic (QT prolongation, arrhythmias)
- Wide postmortem redistribution

**SSRIs**:
- Fluoxetine, sertraline, citalopram
- Serotonin syndrome (hyperthermia, rigidity)
- Safer in overdose than TCAs

**Others**:
- Bupropion (seizure risk)
- Venlafaxine (serotonin-norepinephrine)

#### Antipsychotics
- **Typical**: Haloperidol, chlorpromazine
- **Atypical**: Quetiapine, olanzapine, risperidone
- **Toxicity**: QT prolongation, neuroleptic malignant syndrome

#### Anticonvulsants
- Phenytoin, valproic acid, carbamazepine
- Therapeutic monitoring important
- Toxicity: CNS depression, cardiac effects

### Toxic Substances and Poisons

#### Carbon Monoxide
**Source**: Incomplete combustion (fire, vehicle exhaust, generators)

**Mechanism**: Binds hemoglobin (higher affinity than oxygen)

**Specimen**: Blood (lavender-top tube to prevent dissociation)

**Interpretation**:
- **<10%**: Nonsmoker normal
- **10-20%**: Smoker levels
- **>20%**: Symptomatic (headache, nausea)
- **>40%**: Severe toxicity (confusion, syncope)
- **>60%**: Frequently fatal

**Findings**: Cherry-red livor mortis (not always present)

#### Cyanide
**Sources**: Fire (plastics, wool), suicide agents, industrial

**Mechanism**: Cytochrome oxidase inhibition (cellular hypoxia)

**Specimens**: Blood (special collection, immediate freezing)

**Interpretation**: >3 mg/L toxic

**Findings**: Bright red blood/organs (theoretical)

#### Heavy Metals
**Lead**:
- Chronic exposure (paint, occupational)
- Blood and bone analysis
- Toxicity: Neurological, hematological

**Arsenic**:
- Acute: GI symptoms, cardiovascular collapse
- Chronic: Neuropathy, skin changes
- Hair/nails: Timeline of exposure
- Urine: Speciation (organic vs. inorganic)

**Mercury**:
- Forms: Elemental, organic (methylmercury), inorganic
- Toxicity: Neurological, renal
- Blood and urine analysis

**Thallium**:
- Rodenticides (historical)
- Alopecia characteristic
- Urine analysis

#### Pesticides
**Organophosphates**:
- Mechanism: Cholinesterase inhibition
- Findings: Excessive secretions, miosis, muscle fasciculations
- Testing: Cholinesterase activity (blood)

**Carbamates**:
- Similar to organophosphates
- Reversible inhibition

**Rodenticides**:
- Warfarin and superwarfarins (anticoagulants)
- Brodifacoum: Extremely long half-life

#### Plant and Natural Toxins
- **Digitalis**: Cardiac glycosides
- **Aconite**: Cardiac and neurological
- **Strychnine**: Seizures, muscle rigidity
- **Ricin**: Protein synthesis inhibitor
- **Mushrooms**: Amatoxins (hepatotoxic)

## Interpretation of Toxicology Results

### Factors Affecting Interpretation

#### Postmortem Redistribution
**Mechanism**: Drug movement from tissues to blood after death

**High-Risk Drugs**:
- Lipophilic and basic drugs
- Tricyclic antidepressants
- Antipsychotics
- Some benzodiazepines
- Cocaine, fentanyl

**Mitigation**:
- Use peripheral blood (femoral)
- Compare central and peripheral
- Consider liver/vitreous concentrations
- Interpret with caution

#### Tolerance
- Chronic users tolerate higher concentrations
- "Lethal" concentrations may not cause death in tolerant individuals
- History of use essential
- Prescription records helpful

#### Drug Interactions
**Pharmacokinetic**:
- Altered metabolism (enzyme induction/inhibition)
- Changed absorption or excretion

**Pharmacodynamic**:
- Additive effects (opioid + benzodiazepine + alcohol)
- Synergistic effects (cocaethylene formation)

#### Site-Specific Variations
- Femoral vs. cardiac blood
- Right vs. left cardiac chambers
- Peripheral vs. central locations

#### Postmortem Artifacts
**Bacterial Production**:
- Ethanol formation in decomposition
- Prevented by sodium fluoride

**Chemical Degradation**:
- Cocaine → benzoylecgonine
- Heroin → 6-MAM → morphine (rapid)
- Storage conditions affect stability

### Reporting and Communication

#### Quantitative Results
- Report concentration with units (ng/mL, μg/mL, mg/L)
- Specify specimen type
- Include method and LOQ
- Reference ranges when applicable

#### Qualitative Results
- Detected vs. not detected
- Immunoassay screening: presumptive positive
- Confirmation testing: specific identification

#### Interpretive Comments
- Therapeutic, toxic, or lethal range
- Postmortem considerations
- Clinical effects expected
- Limitations and caveats

### Cause of Death Determination

#### Drug Intoxication Deaths
**Criteria**:
1. Toxicology findings consistent with lethal effect
2. Absence of other adequate cause of death
3. Circumstances support drug exposure
4. Exclusion of natural disease

**Types**:
- Acute intoxication: Single exposure, high levels
- Chronic intoxication: Prolonged exposure, cumulative effect
- Combined drug toxicity: Multiple substances, additive effects

#### Contributing Factors
- Drugs present but not primary cause
- Exacerbate underlying disease
- Impair judgment leading to accident

#### Incidental Findings
- Drugs detected but unrelated to death
- Therapeutic concentrations
- Remote use (cannabis metabolites)

## Special Populations

### Pediatric Considerations
- Different pharmacokinetics
- Smaller blood volumes (limited specimen)
- Consider child abuse/neglect
- Accidental ingestion patterns

### Elderly Considerations
- Polypharmacy common
- Altered metabolism and excretion
- Drug interactions frequent
- Medication errors

### Pregnant Women
- Placental barrier considerations
- Fetal exposure assessment
- Drug effects on fetus
- Maternal-fetal blood comparison

## Emerging Issues

### Novel Psychoactive Substances (NPS)
- Synthetic cannabinoids ("Spice," "K2")
- Synthetic cathinones ("Bath salts")
- Phenethylamines and tryptamines
- Challenge: Constantly changing compounds

### Designer Drugs
- Fentanyl analogs (carfentanil, acetylfentanyl)
- Benzodiazepine analogs (etizolam, flualprazolam)
- Difficulty: Not in standard testing panels

### Drug-Facilitated Sexual Assault
- Rapid metabolism (GHB, flunitrazepam)
- Delayed reporting
- Urine preferred specimen
- Hair analysis for extended window

## Key Points

1. **Specimen Selection**: Appropriate specimens critical for accurate analysis
2. **Peripheral Blood**: Preferred for drug quantitation (less redistribution)
3. **Multiple Specimens**: Correlation improves interpretation
4. **Preservation**: Sodium fluoride prevents microbial ethanol production
5. **Chain of Custody**: Essential for legal admissibility
6. **Screening vs. Confirmation**: Immunoassays presumptive; GC-MS or LC-MS/MS confirmatory
7. **Postmortem Redistribution**: Affects interpretation; use caution with central blood
8. **Context Essential**: Scene, medical history, and autopsy findings guide interpretation
9. **No Universal Lethal Level**: Tolerance, interactions, and individual variation
10. **Objective Reporting**: State findings, interpretations, and limitations clearly

## Case Examples

### Case 1: Opioid Overdose
**History**: 32-year-old male found unresponsive

**Autopsy**: Pulmonary edema, no significant trauma

**Toxicology**:
- Fentanyl (femoral blood): 18 ng/mL
- Morphine (femoral blood): 25 ng/mL
- Benzoylecgonine (urine): Positive

**Interpretation**: Fentanyl concentration in lethal range for non-tolerant individual; morphine likely from heroin use; cocaine metabolite indicates recent use

**Cause of Death**: Acute fentanyl and heroin intoxication

**Manner**: Accident

### Case 2: Carbon Monoxide Poisoning
**History**: Three family members found deceased in home with generator

**Autopsy**: Cherry-red livor mortis

**Toxicology**:
- Carboxyhemoglobin: 68%, 72%, 65%
- Ethanol: Negative

**Interpretation**: Lethal carbon monoxide levels; consistent with generator use in enclosed space

**Cause of Death**: Carbon monoxide intoxication

**Manner**: Accident

### Case 3: Combined Drug Toxicity
**History**: 45-year-old female on multiple medications

**Autopsy**: No anatomical cause of death

**Toxicology**:
- Oxycodone: 0.15 μg/mL (therapeutic high)
- Alprazolam: 0.08 μg/mL (therapeutic)
- Diphenhydramine: 0.5 μg/mL (therapeutic high)
- Ethanol: 0.12% (legally intoxicated)

**Interpretation**: Multiple CNS depressants at therapeutic to high-therapeutic levels; combined effect lethal

**Cause of Death**: Combined drug and ethanol intoxication

**Manner**: Accident (or undetermined based on circumstances)

### Case 4: Chronic Arsenic Poisoning
**History**: 58-year-old male, progressive illness over months

**Autopsy**: Nonspecific findings

**Toxicology**:
- Arsenic (liver): 15 μg/g (elevated, toxic)
- Arsenic (hair segmental analysis): Elevated levels in recent growth
- Arsenic (urine): Not available

**Interpretation**: Chronic arsenic exposure with toxic tissue levels; timeline consistent with illness course

**Cause of Death**: Arsenic intoxication

**Manner**: Homicide (based on investigation)

## References

1. Baselt RC. Disposition of Toxic Drugs and Chemicals in Man, 12th Edition. Biomedical Publications, 2020.

2. Drummer OH. Postmortem Toxicology of Drugs of Abuse. CRC Press, 2004.

3. Flanagan RJ, Taylor A, Watson ID, Whelpton R. Fundamentals of Analytical Toxicology. Wiley, 2007.

4. Levine B. Principles of Forensic Toxicology, 4th Edition. AACC Press, 2013.

5. Karch SB. Postmortem Toxicology of Abused Drugs. CRC Press, 2008.

6. Molina DK. Handbook of Forensic Toxicology for Medical Examiners. CRC Press, 2010.

7. SOFT/AAFS Forensic Toxicology Laboratory Guidelines. 2006.

8. Winek CL, Wahba WW, Winek CL Jr, Balzer TW. Drug and Chemical Blood-Level Data 2001. Forensic Science International, 2001.

9. Jones GR. Postmortem Toxicology. In: Moffat AC, ed. Clarke's Analysis of Drugs and Poisons, 4th Edition. Pharmaceutical Press, 2011.

10. National Association of Medical Examiners. Forensic Toxicology Standards. 2019.
